| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Sin DD | |
| Gan WQ | |||
| Man SF | |||
| Senthilselvan A | |||
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| Meta-analysis in clinical trials | Q27860779 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary | Q29614692 | ||
| Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)) | Q29615986 | ||
| Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers | Q29618581 | ||
| Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination | Q33187560 | ||
| Physiology and pathophysiology of bone remodeling. | Q33701893 | ||
| Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? | Q33829116 | ||
| Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 | ||
| Cachexia | Q34061258 | ||
| Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study | Q34326181 | ||
| Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 | ||
| The human bone marrow response to acute air pollution caused by forest fires | Q34508194 | ||
| COPD and osteoporosis | Q34522020 | ||
| Interaction of alveolar macrophages and airway epithelial cells following exposure to particulate matter produces mediators that stimulate the bone marrow | Q34524783 | ||
| Pulmonary cachexia | Q34774443 | ||
| Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations | Q35534719 | ||
| Chronic obstructive pulmonary disease: molecular and cellularmechanisms | Q35569962 | ||
| Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study | Q36600273 | ||
| Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes | Q38958275 | ||
| Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease | Q41207115 | ||
| Effects of smoking on inflammatory mediators and their relationship to pulmonary dysfunction | Q41445130 | ||
| Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy | Q43788865 | ||
| Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk | Q45259002 | ||
| Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients | Q47338257 | ||
| Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease | Q47366827 | ||
| Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease | Q48016346 | ||
| Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. | Q49119777 | ||
| An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. | Q50539530 | ||
| What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. | Q51643445 | ||
| Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group | Q58421418 | ||
| Systemic effects of chronic obstructive pulmonary disease | Q58840542 | ||
| Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease | Q59669053 | ||
| Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study | Q61696435 | ||
| Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease | Q63729313 | ||
| Lung Function and Risk of Myocardial Infarction and Sudden Cardiac Death | Q67440599 | ||
| Death certificate reporting of confirmed airways obstructive disease | Q70143034 | ||
| Leukocyte count, smoking, and lung function | Q71253983 | ||
| The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease | Q73675027 | ||
| Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels | Q74225996 | ||
| C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men | Q74316335 | ||
| Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study | Q74316767 | ||
| Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study | Q74637821 | ||
| Inflammatory response and body composition in chronic obstructive pulmonary disease | Q77158102 | ||
| Circulating leptin in patients with chronic obstructive pulmonary disease | Q77293107 | ||
| Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins | Q78503936 | ||
| Chronic obstructive pulmonary disease | Q93936786 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| systemic inflammation | Q7663815 | ||
| P304 | page(s) | 574-580 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | |
| P478 | volume | 59 |
| Q55054583 | 8th international conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 1. |
| Q89811112 | A Machine-learning Approach to Forecast Aggravation Risk in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Clinical Indicators |
| Q37205453 | A National Analysis of Complications Following Total Hip Replacement in Patients With Chronic Obstructive Pulmonary Disease |
| Q36081606 | A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation |
| Q35230811 | A bibliometric analysis of the 100 most influential papers on COPD |
| Q34945953 | A cohort study of the impact of tooth loss and periodontal disease on respiratory events among COPD subjects: modulatory role of systemic biomarkers of inflammation |
| Q34621067 | A gender difference in circulating neutrophils in malnourished patients with COPD. |
| Q92990532 | A new cationic palladium(II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models |
| Q42027214 | A new inflammation marker of chronic obstructive pulmonary disease-adiponectin. |
| Q34432112 | A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease |
| Q38334454 | A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation |
| Q37311952 | A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension |
| Q34171853 | A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures |
| Q40498955 | A role for NGF and its receptors TrKA and p75NTR in the progression of COPD. |
| Q40938504 | A systemic defect in Toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD. |
| Q58698886 | Abnormal intrinsic brain activities in stable patients with COPD: a resting-state functional MRI study |
| Q36185811 | Accuracy of symptoms, signs, and C-reactive protein for early chronic obstructive pulmonary disease |
| Q33586131 | Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease |
| Q36894255 | Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management |
| Q37236567 | Acute inflammatory and anabolic systemic responses to peak and constant-work-rate exercise bout in hospitalized patients with COPD. |
| Q34172874 | Acute-phase proteins: As diagnostic tool |
| Q34440546 | Adenosine receptors and vascular inflammation |
| Q36194869 | Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease |
| Q47661793 | Age modification of the relationship between C-reactive protein and fatigue: findings from Understanding Society (UKHLS). |
| Q58591679 | Aging leads to dysfunctional innate immune responses to TLR2 and TLR4 agonists |
| Q28394423 | Air Pollution and Lung Function Loss: The Importance of Metabolic Syndrome |
| Q40623148 | Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study |
| Q35220025 | Airway inflammation contributes to health status in COPD: a cross-sectional study. |
| Q37142605 | Alteration of spontaneous brain activity in COPD patients |
| Q36937623 | Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease |
| Q37417727 | Alveolar hypoxia-induced systemic inflammation: what low PO(2) does and does not do. |
| Q38937853 | An ECLIPSE View of Alpha-1 Antitrypsin Deficiency |
| Q48390718 | An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease |
| Q38066244 | An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products |
| Q54549439 | An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. |
| Q38107279 | Anaemia in chronic obstructive pulmonary disease. Does it really matter? |
| Q35589333 | Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease |
| Q36723445 | Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease |
| Q33774669 | Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke. |
| Q41076989 | Arterial stiffness in symptomatic smokers with normal lung function. |
| Q36909567 | Aspects on pathophysiological mechanisms in COPD. |
| Q55263180 | Assessment of anti-reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux. |
| Q48355090 | Assessment of dietary fat intake and innate immune activation as risk factors for impaired lung function. |
| Q36294520 | Assessment of hypoxia in children with cystic fibrosis. |
| Q47334748 | Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography. |
| Q40846338 | Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria. |
| Q36818940 | Assessment of the quantity of microorganisms associated with bronchiectasis in saliva, sputum and nasal lavage after periodontal treatment: a study protocol of a randomised controlled trial. |
| Q90713990 | Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study |
| Q83725158 | Association between "Malnutrition Inflammation Score" and airway obstruction in patients awaiting renal transplantation: a preliminary study |
| Q89898692 | Association between C reactive protein and all-cause mortality in the ELSA-Brasil cohort |
| Q35071202 | Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study |
| Q93075758 | Association between blood pressure, inflammation and spirometry parameters in chronic obstructive pulmonary disease |
| Q33730864 | Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women's Health and Aging Studies I and II |
| Q55230101 | Association between polymorphism of tumor necrosis factor alpha (tnfα) in the region -308 g/a with tinnitus in the elderly with a history of occupational noise exposure. |
| Q41351240 | Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis |
| Q38580083 | Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q92479876 | Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q35421066 | Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study |
| Q37113883 | Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study |
| Q37115862 | Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences |
| Q36299000 | Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease |
| Q47646333 | Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts. |
| Q24811762 | Associations between health effects and particulate matter and black carbon in subjects with respiratory disease |
| Q33481269 | Associations between statins and COPD: a systematic review. |
| Q34584449 | Autoantibodies in patients with chronic obstructive pulmonary disease |
| Q37841941 | Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease |
| Q38838130 | Big insights from small volumes: deciphering complex leukocyte behaviors using microfluidics. |
| Q34606647 | Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study |
| Q34510319 | Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD |
| Q82022906 | Biomarkers of systemic inflammation in stable and exacerbation phases of COPD |
| Q37012728 | Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease |
| Q38109057 | Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice? |
| Q47177659 | Body weight and mortality in COPD: focus on the obesity paradox |
| Q45723471 | Bone mineral density in patients with chronic obstructive pulmonary disease who are candidates for lung transplant |
| Q37610950 | Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease |
| Q36842955 | Brain-derived neurotrophic factor in cigarette smoke-induced airway hyperreactivity |
| Q35537717 | C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study |
| Q44785204 | C-Reactive Protein at Discharge, Diabetes Mellitus and ≥ 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
| Q36318334 | C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations. |
| Q36184252 | C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease |
| Q33898168 | C-reactive protein and risk of lung cancer |
| Q37115899 | C-reactive protein correlates with tissue oxygen availability in patients with stable COPD |
| Q43938873 | C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection |
| Q36029240 | C-reactive protein levels in stable COPD patients: a case-control study |
| Q35672663 | C-reactive protein levels, airflow obstruction, and chronic kidney disease |
| Q49148594 | C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. |
| Q42268471 | C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations |
| Q54051804 | CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. |
| Q26786812 | COPD and its comorbidities: Impact, measurement and mechanisms |
| Q28392377 | COPD and levels of Hsp70 (HSPA1A) and Hsp27 (HSPB1) in plasma and lymphocytes among coal workers: a case-control study |
| Q26746530 | COPD and stroke: are systemic inflammation and oxidative stress the missing links? |
| Q37231865 | COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention |
| Q37139528 | COPD as a systemic disease |
| Q37496470 | COPD assessment test score and serum C-reactive protein levels in stable COPD patients |
| Q36672850 | COPD disease severity and innate immune response to pathogen-associated molecular patterns |
| Q37233745 | COPD phenotype description using principal components analysis |
| Q37856579 | COPD: a multifactorial systemic disease |
| Q35994482 | Cadmium-mediated toxicity of lung epithelia is enhanced through NF-κB-mediated transcriptional activation of the human zinc transporter ZIP8. |
| Q25257397 | Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]. |
| Q33591899 | Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update |
| Q61797897 | Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)-Current Considerations for Clinical Practice |
| Q23918235 | Cardiovascular biomarkers predict susceptibility to lung injury in World Trade Center dust-exposed firefighters |
| Q37098445 | Cardiovascular injury and repair in chronic obstructive pulmonary disease |
| Q36944067 | Cardiovascular risk in chronic obstructive pulmonary disease |
| Q54739404 | Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. |
| Q37018812 | Changing the burden of COPD mortality |
| Q38944856 | Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care |
| Q34684222 | Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? |
| Q35906553 | Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland |
| Q38065457 | Chronic bronchial infection in COPD. Is there an infective phenotype? |
| Q36446491 | Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk |
| Q36793296 | Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells |
| Q36402823 | Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony |
| Q48393784 | Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease |
| Q26767365 | Chronic obstructive pulmonary disease and obstructive sleep apnoea-the overlap syndrome |
| Q34228984 | Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat |
| Q37367648 | Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity |
| Q43253464 | Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors |
| Q38183116 | Chronic obstructive pulmonary disease in stage I non-small cell lung cancer that underwent anatomic resection: the role of a recurrence promoter |
| Q36405415 | Chronic obstructive pulmonary disease phenotype desaturator with hypoxic vascular remodelling and pulmonary hypertension obtained by cluster analysis. |
| Q39867138 | Chronic obstructive pulmonary disease phenotypes: the future of COPD. |
| Q57756395 | Chronic obstructive pulmonary disease severity and cardiovascular outcomes |
| Q58762142 | Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach |
| Q36067003 | Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease |
| Q36443665 | Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities |
| Q37598879 | Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults |
| Q36654855 | Chronic obstructive pulmonary disease: clinical signs and infections |
| Q37988881 | Chronic obstructive pulmonary disease: consequences beyond the lung. |
| Q33543733 | Chronic obstructive pulmonary disease: effects beyond the lungs |
| Q33600138 | Chronic obstructive pulmonary disease: towards pharmacogenetics |
| Q42407067 | Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner |
| Q36700389 | Circulating alpha1-antitrypsin in the general population: determinants and association with lung function |
| Q33954480 | Circulating hematopoietic progenitor cells are decreased in COPD. |
| Q33878775 | Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease |
| Q99570756 | Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 |
| Q42913372 | Clinical and symptomatological reflections: the fascial system |
| Q37546161 | Clinical implications of cytokines in the critical-care unit |
| Q51216752 | Clinical importance of cross-sectional area of intercostal muscles in patients with chronic obstructive pulmonary disease. |
| Q37030847 | Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient |
| Q43909160 | Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function |
| Q39174951 | Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories |
| Q36710134 | Cognitive status among patients with chronic obstructive pulmonary disease |
| Q87428168 | Coming off the GOLD standard |
| Q34004971 | Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease |
| Q37103715 | Comorbidities in chronic obstructive pulmonary disease |
| Q30989356 | Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey |
| Q34564347 | Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? |
| Q47653643 | Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both |
| Q37709578 | Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease |
| Q51063268 | Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations. |
| Q37815485 | Consequences of physical inactivity in chronic obstructive pulmonary disease. |
| Q35892456 | Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD |
| Q26786159 | Contribution of air pollution to COPD and small airway dysfunction |
| Q52327746 | Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress. |
| Q37356441 | Cross-sectional associations of pulmonary function with systemic inflammation and oxidative stress in individuals with chronic spinal cord injury |
| Q37165610 | Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women |
| Q33568552 | Cytokine inhibition in the treatment of COPD. |
| Q34080315 | DAXAS and COPD Correlation with Cancer |
| Q58317578 | Declining Lung Function and Cardiovascular Risk: The ARIC Study |
| Q47651592 | Defining the relationship between COPD and CVD: what are the implications for clinical practice? |
| Q37151413 | Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids |
| Q36585739 | Depression, body mass index, and chronic obstructive pulmonary disease - a holistic approach |
| Q37754541 | Developments in drugs for the treatment of chronic obstructive pulmonary disease |
| Q38203153 | Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases |
| Q26750759 | Diesel exhaust: current knowledge of adverse effects and underlying cellular mechanisms |
| Q58694600 | Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD |
| Q43452631 | Differences in local and systemic inflammatory markers in patients with obstructive airways disease |
| Q36203159 | Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release |
| Q33732176 | Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients |
| Q38899787 | Differential proteomic analysis of mouse macrophages exposed to adsorbate-loaded heavy fuel oil derived combustion particles using an automated sample-preparation workflow |
| Q39147345 | Disease Severity Prediction by Spirometry in Adults with Visceral Leishmaniasis from Minas Gerais, Brazil |
| Q39587342 | Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice. |
| Q40066585 | Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease |
| Q38604749 | Does Improving Exercise Capacity and Daily Activity Represent the Holistic Perspective of a New COPD Approach? |
| Q46646565 | Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality? |
| Q34538742 | Domains of chronic stress, lifestyle factors, and allostatic load in middle-aged Mexican-American women |
| Q30249747 | Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis |
| Q45817425 | Dysregulated adipokine metabolism in chronic obstructive pulmonary disease |
| Q37075235 | Ectopic lymphoid tissues and local immunity |
| Q48461345 | Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. |
| Q48066392 | Effect of bufei granule on stable chronic obstructive pulmonary disease: a randomized, double blinded, placebo-controlled, and multicenter clinical study. |
| Q51774720 | Effect of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation. |
| Q89495772 | Effect of pulegone on the NLPR3 inflammasome during inflammatory activation of THP-1 cells |
| Q51101328 | Effectiveness of essential amino acid supplementation in stimulating whole body net protein anabolism is comparable between COPD patients and healthy older adults. |
| Q61445076 | Effectiveness of long-term using statins in COPD - a network meta-analysis |
| Q33735832 | Effects and mechanism of bufei yishen formula in a rat chronic obstructive pulmonary disease model |
| Q57790167 | Effects of acupuncture on nutritional state of patients with stable chronic obstructive pulmonary disease (COPD): re-analysis of COPD acupuncture trial, a randomized controlled trial |
| Q55349415 | Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD. |
| Q42964153 | Effects of budesonide on P38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells |
| Q96306099 | Effects of conjugated linoleic acid supplementation on serum levels of interleukin-6 and sirtuin 1 in COPD patients |
| Q51745591 | Effects of indole alkaloids from leaf of Alstonia scholaris on post-infectious cough in mice. |
| Q37785279 | Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease |
| Q37636173 | Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease |
| Q36880195 | Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome |
| Q36257981 | Effects of periodontal treatment on exacerbation frequency and lung function in patients with chronic periodontitis: study protocol of a 1-year randomized controlled trial |
| Q35990454 | Effects of peripheral neuropathy on exercise capacity and quality of life in patients with chronic obstructive pulmonary diseases |
| Q42829608 | Effects of short- and long-term exposures to ambient air pollution on COPD. |
| Q54973021 | Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial. |
| Q44363961 | Effects of whole body vibration training in patients with severe chronic obstructive pulmonary disease |
| Q35686996 | Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial |
| Q37984088 | Emerging drugs for chronic obstructive pulmonary disease. |
| Q64951602 | Endotoxin-Induced Emphysema Exacerbation: A Novel Model of Chronic Obstructive Pulmonary Disease Exacerbations Causing Cardiopulmonary Impairment and Diaphragm Dysfunction. |
| Q23912391 | Enlarged pulmonary artery is predicted by vascular injury biomarkers and is associated with WTC-lung injury in exposed fire fighters: a case-control study |
| Q91501033 | Environmental correlates of chronic obstructive pulmonary disease in 96 779 participants from the UK Biobank: a cross-sectional, observational study |
| Q47151695 | Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker |
| Q36240709 | Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD. |
| Q37441610 | Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD. |
| Q36929346 | Evaluation of C-Reactive Protein in Patients with Chronic Obstructive Pulmonary Disease |
| Q46409999 | Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease |
| Q34126821 | Evaluation of exogenous melatonin administration in improvement of sleep quality in patients with chronic obstructive pulmonary disease |
| Q34126502 | Evaluation of high-sensitivity C-reactive protein in acute asthma. |
| Q92648544 | Evaluation of lung parenchyma, blood vessels, and peripheral blood lymphocytes as a potential source of acute phase reactants in patients with COPD |
| Q33511666 | Evaluation of psychological and physiological predictors of fatigue in patients with COPD. |
| Q37569135 | Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial. |
| Q34360211 | Evaluation of von Willebrand factor in COPD patients. |
| Q34993732 | Evidence of lung function for stratification of cardiovascular disease risk |
| Q35170150 | Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease |
| Q39011225 | Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats |
| Q53449110 | Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer. |
| Q40566316 | Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD. |
| Q41974760 | Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease |
| Q41687136 | Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis. |
| Q40082261 | FEV1 and FVC and systemic inflammation in a spinal cord injury cohort |
| Q47395738 | Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPD. |
| Q40043422 | Factors associated with pulmonary impairment in HIV-infected South African adults |
| Q37071021 | Factors contributing to muscle wasting and dysfunction in COPD patients. |
| Q39399877 | Feasibility of ω-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial. |
| Q50883932 | Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD. |
| Q26777960 | Fine particulate matter in acute exacerbation of COPD |
| Q33804102 | Flavone deglycosylation increases their anti-inflammatory activity and absorption |
| Q36215313 | Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases |
| Q35158568 | Fracture prevention in COPD patients; a clinical 5-step approach |
| Q40786235 | Frailty in Pulmonary and Critical Care Medicine |
| Q52581028 | Frailty phenotypes and mortality after lung transplantation: a prospective cohort study. |
| Q33276258 | Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population |
| Q34393981 | Frequency of the mdr-1 C>T gene polymorphism in patients with COPD. |
| Q49268520 | Frequency-dependent airway hyperresponsiveness in a mouse model of emphysema and allergic inflammation. |
| Q36000101 | Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease |
| Q37776726 | Gamma-Glutamyl Transferase: The Silent Partner? |
| Q33803872 | Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study |
| Q37236587 | Gender differences in the association between C-reactive protein, lung function impairment, and COPD. |
| Q61445102 | Gender- and Age-Specific Associations Between Body Fat Composition and C-Reactive Protein with Lung Function: A Cross-Sectional Study |
| Q51989419 | Gene expression profiling of human lung tissue from smokers with severe emphysema. |
| Q36579793 | Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice |
| Q37277633 | Genetic variability of inflammatory genes in the Brazilian population |
| Q99728727 | Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies |
| Q36376519 | Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma? |
| Q37679759 | Heart-lung interaction via infection |
| Q51503758 | High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis. |
| Q46621885 | High prevalence of COPD in atherosclerosis patients |
| Q34255448 | High sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease |
| Q35571972 | High-mobility group box-1 induces vascular remodelling processes via c-Jun activation |
| Q30999453 | Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People - Data from the Berlin Aging Study II. |
| Q37225778 | Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD |
| Q35955467 | Host-microbiome interactions in acute and chronic respiratory infections |
| Q31106367 | Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study |
| Q30478614 | Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease |
| Q35023212 | Hypoxemia in patients with COPD: cause, effects, and disease progression |
| Q44665278 | IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. |
| Q33416183 | IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study |
| Q36797618 | INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units |
| Q35797789 | Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS. |
| Q35825925 | Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity |
| Q47702857 | Imbalance between Subpopulations of Regulatory T Cells in Patients with Acute Exacerbation of COPD. |
| Q45910638 | Imbalance between subpopulations of regulatory T cells in COPD. |
| Q83786871 | Imbalance of circulating T-lymphocyte subpopulation in COPD and its relationship with CAT performance |
| Q37500727 | Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention |
| Q45017800 | Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial? |
| Q64072478 | Impacts of event-specific air quality improvements on total hospital admissions and reduced systemic inflammation in COPD patients |
| Q40468792 | Impaired calcium signaling in muscle fibers from intercostal and foot skeletal muscle in a cigarette smoke-induced mouse model of COPD. |
| Q29248598 | Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese |
| Q38710985 | Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease. |
| Q48787917 | Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention. |
| Q92211595 | Increased IFN-γ-producing Th17/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease |
| Q47639331 | Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD. |
| Q40474641 | Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score. |
| Q44210553 | Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea |
| Q90636017 | Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk |
| Q41960258 | Inflammation, caveolae and CD38-mediated calcium regulation in human airway smooth muscle. |
| Q88573108 | Inflammation-on-a-Chip: Probing the Immune System Ex Vivo |
| Q28395126 | Inflammation-related effects of diesel engine exhaust particles: studies on lung cells in vitro |
| Q35996778 | Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis |
| Q48611059 | Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. |
| Q47424182 | Inflammatory biomarkers and radiologic measurements in never-smokers with COPD: A cross-sectional study from the CODA cohort |
| Q28071311 | Inflammatory bowel disease and airway diseases |
| Q33880491 | Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy. |
| Q37544889 | Inflammatory disease processes and interactions with nutrition |
| Q37305923 | Inflammatory markers and longitudinal lung function decline in the elderly |
| Q36036012 | Inflammatory markers and mortality among US adults with obstructive lung function |
| Q36148605 | Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects |
| Q42686567 | Inflammatory markers in chronic obstructive pulmonary disease patients with different α1 antitrypsin genotypes |
| Q45894281 | Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome |
| Q48448565 | Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. |
| Q87696111 | Influence of Statin Therapy on Exacerbation Frequency in Patients with Chronic Obstructive Pulmonary Disease |
| Q89992965 | Influence of atrial fibrillation on cardiac prognosis in chronic obstructive pulmonary disease |
| Q27026426 | Influence of diet and obesity on COPD development and outcomes |
| Q37153293 | Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease |
| Q101226257 | Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study |
| Q34065276 | Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective |
| Q36062019 | Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit? |
| Q88657487 | Inhaled glucocorticoids are associated with vertebral fractures in COPD patients |
| Q44231339 | Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery |
| Q42603766 | Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD rats |
| Q90707922 | Inhibition of NADPH Oxidase-Derived Reactive Oxygen Species Decreases Expression of Inflammatory Cytokines in A549 Cells |
| Q36305330 | Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"? |
| Q50443731 | Inspiratory resistive breathing induces acute lung injury. |
| Q37739257 | Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD |
| Q47639229 | Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease |
| Q42212096 | Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease |
| Q43955644 | Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis |
| Q58840516 | Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease |
| Q41158533 | Invasive coronary angiography in patients with acute exacerbated COPD and elevated plasma troponin |
| Q36120008 | Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study |
| Q33994883 | Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. |
| Q33949352 | Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? |
| Q36760107 | Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? |
| Q35189528 | Is inflammatory chronic obstructive pulmonary disease a coronary heart disease risk equivalent? A longitudinal analysis of the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. |
| Q43526426 | Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics. |
| Q53301493 | L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker. |
| Q57789349 | Left ventricular dysfunction in relation with systemic inflammation in chronic obstructive pulmonary disease patients |
| Q26865989 | Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases |
| Q33917491 | Leptin receptor polymorphisms and lung function decline in COPD |
| Q84532285 | Leptin, adiponectin, and asthma: findings from a population-based cohort study |
| Q51536953 | Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease. |
| Q47335964 | Levels of circulating cortisol and cytokines in members of the Canadian Armed Forces: Associations with age, sex and anthropometry |
| Q47911925 | Lipids of erythrocyte membranes of COPD patients: a quantitative and qualitative study |
| Q45282765 | Liver growth factor treatment reverses emphysema previously established in a cigarette smoke exposure mouse model. |
| Q38624850 | Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations |
| Q41496258 | Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D |
| Q37396158 | Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study |
| Q47297954 | Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass |
| Q36036900 | Low bone mineral density in COPD patients with osteoporosis is related to low daily physical activity and high COPD assessment test scores |
| Q43837354 | Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery |
| Q36283226 | Lung Disease and Hypertension |
| Q24658577 | Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men-the British Regional Heart Study |
| Q34065973 | Lung function and blood markers of nutritional status in non-COPD aging men with smoking history: a cross-sectional study |
| Q34777879 | Lung function and risk for heart failure among older adults: the Health ABC Study |
| Q34084538 | Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation |
| Q23915586 | Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control study |
| Q51466028 | Malnutrition screening in patients admitted to hospital with an exacerbation of chronic obstructive pulmonary disease and its association with patient outcomes. |
| Q97538245 | Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients |
| Q38066413 | Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges |
| Q37168317 | Markers of early disease and prognosis in COPD. |
| Q36722428 | Markers of lower respiratory tract infections in emergency departments |
| Q38095512 | Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis |
| Q44757661 | Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease |
| Q35672964 | Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters |
| Q37224514 | Measurement of the acute inflammatory response to walking exercise in COPD: effects of pulmonary rehabilitation. |
| Q36859410 | Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. |
| Q42795552 | Medical Nutrition Therapy based on Nutrition Intervention for a Patient with Chronic Obstructive Pulmonary Disease |
| Q42036397 | Meta-analysis of routine blood tests as predictors of mortality in COPD. |
| Q62731134 | Metabolic Syndrome and Air Pollution: A Narrative Review of Their Cardiopulmonary Effects |
| Q23910631 | Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study |
| Q33554524 | Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation |
| Q42853726 | Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study |
| Q37655139 | Methods for the assessment of peripheral muscle fatigue and its energy and metabolic determinants in COPD. |
| Q40007020 | MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD. |
| Q57557608 | Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation |
| Q34539050 | Mobile-phone-based home exercise training program decreases systemic inflammation in COPD: a pilot study |
| Q92464037 | Moderate-intensity physical activity reduces systemic inflammation and maintains cardiorespiratory function following chronic particulate matter2.5 exposure in rats |
| Q36779299 | Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy |
| Q47276632 | Molecular modeling of Gly80 and Ser80 variants of human group IID phospholipase A2 and their receptor complexes: potential basis for weight loss in chronic obstructive pulmonary disease |
| Q36742804 | Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena |
| Q26775701 | Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings |
| Q51558183 | Muscular Dysfunction in COPD: Systemic Effect or Deconditioning? |
| Q42181451 | Musculoskeletal disorders in chronic obstructive pulmonary disease |
| Q38730058 | NPS2143 Inhibits MUC5AC and Proinflammatory Mediators in Cigarette Smoke Extract (CSE)-Stimulated Human Airway Epithelial Cells |
| Q50485344 | Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. |
| Q37102014 | Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons |
| Q35227855 | Nutrition and respiratory health--feature review |
| Q88771482 | Nutrition in chronic obstructive pulmonary disease: A review |
| Q35671700 | Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD. |
| Q51763281 | Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases. |
| Q55212210 | Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations. |
| Q24202330 | Nutritional supplementation for stable chronic obstructive pulmonary disease |
| Q28598397 | Only severe COPD is associated with being underweight: results from a population survey |
| Q84626299 | Optimization of a procedure to accurately detect equine TNFα in serum samples |
| Q35173349 | Osteoporosis in chronic obstructive pulmonary disease |
| Q53044916 | Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality. |
| Q40808876 | Oxidative and proteolysis-related parameters of skeletal muscle from hamsters with experimental pulmonary emphysema: a comparison between papain and elastase induction. |
| Q33755995 | Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study |
| Q92044310 | Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies |
| Q38091961 | Pathophysiology of muscle dysfunction in COPD. |
| Q44267225 | Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease |
| Q53613245 | Peripapillary choroidal thickness in patients with chronic obstructive pulmonary disease. |
| Q41854378 | Persistence of systemic inflammation in COPD in spite of smoking cessation |
| Q34157742 | Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS |
| Q34280020 | Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype |
| Q42011965 | Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy |
| Q48458622 | Phenotyping primary human microglia: tight regulation of LPS responsiveness. |
| Q38595360 | Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs |
| Q38258537 | Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold? |
| Q92426863 | Physical Activity in Overlap Syndrome of COPD and Obstructive Sleep Apnea: Relationship With Markers of Systemic Inflammation |
| Q36201980 | Physical activity and modulation of systemic low-level inflammation |
| Q38690517 | Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium |
| Q35077912 | Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD. |
| Q53065497 | Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease. |
| Q37224504 | Plasma homocysteine is elevated in COPD patients and is related to COPD severity |
| Q37700518 | Plasma inflammatory mediators associated with bone metabolism in COPD |
| Q53768286 | Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study. |
| Q37890370 | Pneumocystis jirovecii colonization in chronic pulmonary disease |
| Q34797266 | Poor clinical outcomes among pneumonia patients with depressive disorder |
| Q33928645 | Preclinical vascular disease identifies smokers at risk for COPD. |
| Q47139781 | Predictive value of ADAMTS-13 on concealed chronic renal failure in COPD patients |
| Q51684825 | Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease. |
| Q34285092 | Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients. |
| Q33683010 | Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score |
| Q37282686 | Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia |
| Q36727264 | Preoperative Predictors of Long-Term Mortality after Elective Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm |
| Q37067584 | Preoperative white blood cell count and risk of 30-day readmission after cardiac surgery. |
| Q47105400 | Prevalence of Osteoporosis in Korean Patients with Chronic Obstructive Pulmonary Disease and Their Health-related Quality of Life According to the Korea National Health and Nutrition Examination Survey 2008-2011. |
| Q36202909 | Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q58712530 | Prevalence of chronic obstructive pulmonary disease (COPD) among rheumatoid arthritis: results from national inpatient database |
| Q40557048 | Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease |
| Q38172838 | Prevalence of systemic inflammation and micronutrient imbalance in patients with complex abdominal hernias. |
| Q90859276 | Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells |
| Q36225770 | Profiling serum biomarkers in patients with COPD: associations with clinical parameters |
| Q38621350 | Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. |
| Q35202177 | Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review |
| Q57955615 | Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease |
| Q37144395 | Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer |
| Q28387692 | Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial |
| Q36225993 | Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men |
| Q37098776 | Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women |
| Q45682609 | Protein-protein interaction network analysis in chronic obstructive pulmonary disease |
| Q37763933 | Proteomics in detection and monitoring of asthma and smoking-related lung diseases |
| Q36221051 | Pulmonary Hypertension Secondary to COPD. |
| Q36776338 | Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study |
| Q36265508 | Pulmonary oxygen uptake and muscle deoxygenation kinetics during heavy intensity cycling exercise in patients with emphysema and idiopathic pulmonary fibrosis |
| Q34914760 | Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort |
| Q36148662 | Raised CRP levels mark metabolic and functional impairment in advanced COPD. |
| Q40114181 | Rapid decline in lung function is temporally associated with greater metabolically active adiposity in a longitudinal study of healthy adults |
| Q37426720 | Recent advances in pre-clinical mouse models of COPD. |
| Q62731127 | Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review |
| Q45059034 | Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease |
| Q36169173 | Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD |
| Q46057464 | Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients |
| Q36249604 | Regulation of Neutrophil Degranulation and Cytokine Secretion: A Novel Model Approach Based on Linear Fitting. |
| Q36216587 | Regulation of airway mucin gene expression |
| Q46820311 | Regulation of store-operated Ca2+ entry by CD38 in human airway smooth muscle. |
| Q91898704 | Regulatory T Cells in Respiratory Health and Diseases |
| Q41038503 | Relation between respiratory function and arterial stiffness assessed using brachial-ankle pulse wave velocity in healthy workers |
| Q36293943 | Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients |
| Q90582183 | Relationship between Vitamin D Level and Serum TNF-α Concentration on the Severity of Chronic Obstructive Pulmonary Disease |
| Q39410233 | Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis |
| Q60907685 | Relationships of Haptoglobin Phenotypes with Systemic Inflammation and the Severity of Chronic Obstructive Pulmonary Disease |
| Q49922922 | Repetitive TLR-3 activation in the lung induces skeletal muscle adaptations and cachexia. |
| Q35032256 | Repression of CC16 by cigarette smoke (CS) exposure. |
| Q34903298 | Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function |
| Q37979250 | Respiratory diseases and muscle dysfunction |
| Q34611811 | Respiratory impairment and systemic inflammation in cedar asthmatics removed from exposure |
| Q36658551 | Resting and Post-Exercise Ankle-Brachial Index Measurements to Diagnose Asymptomatic Peripheral Arterial Disease in Middle Aged and Elderly Chronic Obstructive Pulmonary Disease Patients: A Pilot Study |
| Q36973036 | Restrictive pulmonary deficit is associated with inflammation in sub-optimally controlled obese diabetics |
| Q35013194 | Retinoic acid receptor alpha: One of plasma biomarkers associated with exacerbation of chronic obstructive pulmonary disease |
| Q47655268 | Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan |
| Q41381535 | Risk of Frailty in Elderly With COPD: A Population-Based Study |
| Q90353425 | Risk of chronic obstructive pulmonary disease in healthy individuals with high C-reactive protein levels by smoking status: a population-based cohort study in Korea |
| Q58726183 | Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation |
| Q38137141 | Roflumilast : the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD. |
| Q37681577 | Roflumilast in chronic obstructive pulmonary disease: evidence from large trials |
| Q39020015 | Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations. |
| Q26770501 | Roflumilast: a review of its use in the treatment of COPD |
| Q37778289 | Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD. |
| Q43061644 | Roflumilast: systemic therapy for chronic obstructive pulmonary disease |
| Q42146567 | Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients |
| Q27015002 | Role of autophagy in COPD skeletal muscle dysfunction |
| Q27025502 | Role of specific dietary amino acids in clinical conditions |
| Q41998755 | Role of transient receptor potential C3 in TNF-alpha-enhanced calcium influx in human airway myocytes |
| Q57257741 | Roles of DNA repair enzyme OGG1 in innate immunity and its significance for lung cancer |
| Q28387428 | SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort |
| Q54970037 | SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease. |
| Q34415156 | Salmeterol combined with fluticasone propionate improved COPD in patients during stable stage. |
| Q42753096 | Sarcopaenia in chronic obstructive pulmonary disease |
| Q64969557 | Sarcopenia Associated with Chronic Obstructive Pulmonary Disease. |
| Q37664782 | Sarcopenia correlates with systemic inflammation in COPD. |
| Q90661409 | Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors |
| Q40061182 | Secondhand hookah smoke: an occupational hazard for hookah bar employees. |
| Q37295182 | Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study |
| Q92068191 | Serum Alpha-1 Antitrypsin Levels and the Clinical Course of Chronic Obstructive Pulmonary Disease |
| Q39428853 | Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran. |
| Q37563167 | Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification. |
| Q33627657 | Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters |
| Q41401443 | Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency |
| Q35963109 | Serum Vitamin A and Inflammatory Markers in Individuals with and without Chronic Obstructive Pulmonary Disease |
| Q45908560 | Serum angiopoietin-2 and CRP levels during COPD exacerbations. |
| Q92974918 | Serum inflammatory markers and nutritional status in patients with stable chronic obstructive pulmonary disease |
| Q51799739 | Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. |
| Q90497614 | Short-term variations of optic coherence tomography findings in mild and severe chronic obstructive pulmonary disease |
| Q36849827 | Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease |
| Q37128050 | Should the cut-off value of D-dimer be elevated to exclude pulmonary embolism in acute exacerbation of COPD? |
| Q48039852 | Six-year trajectory of objective physical function in persons with depressive and anxiety disorders |
| Q37115925 | Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease |
| Q42721660 | Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? |
| Q42331967 | Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases. |
| Q38174717 | Sleep-related disorders in chronic obstructive pulmonary disease |
| Q89536887 | Smokers with COPD Show a Shift in Energy and Nitrogen Metabolism at Rest and During Exercise |
| Q34663701 | Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1ra |
| Q33939434 | Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. |
| Q39819519 | Social Inequalities in Inflammation |
| Q41807544 | Social disruption induces lung inflammation |
| Q36464916 | Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease |
| Q42374565 | Speckle tracking echocardiography in chronic obstructive pulmonary disease and overlapping obstructive sleep apnea |
| Q40765651 | Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease. |
| Q33995697 | Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study |
| Q57792200 | Statin for Tuberculosis and Pneumonia in Patients with Asthma⁻Chronic Pulmonary Disease Overlap Syndrome: A Time-Dependent Population-Based Cohort Study |
| Q51688137 | Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. |
| Q42572130 | Statin use reduces decline in lung function: VA Normative Aging Study |
| Q24188188 | Statins versus placebo for people with chronic obstructive pulmonary disease (COPD) |
| Q36036223 | Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease |
| Q39857892 | Stress and inflammation: a biobehavioral approach for nursing research |
| Q43096627 | Studies of gamma-glutamyl transferase in alpha-1 antitrypsin deficiency. |
| Q47214661 | Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease |
| Q38931343 | Subclinical cardiovascular disease in patients with chronic obstructive pulmonary disease: a systematic review |
| Q37578142 | Superoxide release from contracting skeletal muscle in pulmonary TNF-α overexpression mice |
| Q42759714 | Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease |
| Q36645461 | Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids |
| Q47366696 | Systemic Markers of Adaptive and Innate Immunity are Associated with COPD Severity and Spirometric Disease Progression |
| Q41124329 | Systemic White Blood Cell Count as a Biomarker Associated with Severity of Chronic Obstructive Lung Disease. |
| Q28728578 | Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity |
| Q37362575 | Systemic consequences of COPD. |
| Q38006928 | Systemic inflammation and comorbidities in chronic obstructive pulmonary disease |
| Q36225737 | Systemic inflammation and decline in lung function in a general population: a prospective study |
| Q36169109 | Systemic inflammation and lung function in young adults |
| Q42502252 | Systemic inflammation and priming of peripheral blood leukocytes persist during clinical remission in horses with heaves |
| Q42764765 | Systemic inflammation and progression of COPD. |
| Q28390485 | Systemic inflammation and reduced pulmonary function in chronic spinal cord injury |
| Q23909920 | Systemic inflammation associated with World Trade Center dust exposures and airway abnormalities in the local community |
| Q36164159 | Systemic inflammation in 222.841 healthy employed smokers and nonsmokers: white blood cell count and relationship to spirometry |
| Q36293904 | Systemic inflammation in COPD in relation to smoking status |
| Q36686862 | Systemic inflammation in COPD: is genetic susceptibility a key factor? |
| Q33939195 | Systemic inflammation in chronic obstructive pulmonary disease: a population-based study |
| Q47272312 | Systemic inflammation in patients with chronic obstructive pulmonary disease: one size no longer fits all! |
| Q36851815 | Systemic inflammation, depression and obstructive pulmonary function: a population-based study |
| Q38056532 | Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease |
| Q36726350 | Systemic manifestations in chronic obstructive pulmonary disease. |
| Q36367744 | TNF-α is associated with loss of lean body mass only in already cachectic COPD patients |
| Q34045375 | TNFA-863 polymorphism is associated with a reduced risk of chronic obstructive pulmonary disease: a replication study |
| Q36779343 | Tackling COPD: a multicomponent disease driven by inflammation |
| Q24202338 | Tai Chi for chronic obstructive pulmonary disease (COPD) |
| Q26471513 | Tai Chi for chronic obstructive pulmonary disease (COPD) |
| Q36689652 | Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD. |
| Q36956720 | Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease |
| Q37308018 | Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. |
| Q53450853 | The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study. |
| Q47972423 | The Correlation of Serum Brain Natriuretic Peptide and Interleukin-6 with Quality of Life Using Chronic Obstructive Pulmonary Disease Assessment Test. |
| Q41170536 | The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy |
| Q38608866 | The Gut-Liver-Lung Axis. Modulation of the Innate Immune Response and Its Possible Role in Chronic Obstructive Pulmonary Disease |
| Q87695964 | The Importance of Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease |
| Q26828971 | The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease |
| Q52605888 | The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis. |
| Q40090026 | The Relationship between Dietary Fiber Intake and Lung Function in the National Health and Nutrition Examination Surveys. |
| Q60921746 | The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review |
| Q37733309 | The Saudi Guidelines for the Diagnosis and Management of COPD. |
| Q33241996 | The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care |
| Q36980625 | The association between COPD and heart failure risk: a review |
| Q91356169 | The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis |
| Q39282602 | The association between periodontal disease and chronic obstructive pulmonary disease: a case control study |
| Q31025999 | The association between systemic inflammatory cellular levels and lung function: a population-based study |
| Q37382225 | The association between the body composition and lifestyle affecting pulmonary function in Japanese workers |
| Q51373002 | The association of low bone mineral density with systemic inflammation in clinically stable COPD. |
| Q36669465 | The challenges of chronic obstructive pulmonary diseases (COPD)--a perspective |
| Q37397834 | The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients |
| Q37212032 | The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial |
| Q48403766 | The effects of Chinese yam-epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease. |
| Q45998753 | The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. |
| Q47909186 | The evaluation of retinal and choroidal structural changes by optical coherence tomography in patients with chronic obstructive pulmonary disease |
| Q36300138 | The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases |
| Q37930205 | The future of chronic obstructive pulmonary disease treatment--difficulties of and barriers to drug development |
| Q41874928 | The holistic perspective of chronic obstructive pulmonary disease: doubt some more |
| Q87045655 | The impact of hypoxemia on serum total and free prostate-specific antigen levels in patients with chronic obstructive pulmonary disease |
| Q35862156 | The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease |
| Q43343959 | The levels of inflammatory markers and oxidative stress in individuals occupationally exposed to municipal solid waste in Ogun State, South West Nigeria |
| Q35049038 | The lung inflammation and skeletal muscle wasting induced by subchronic cigarette smoke exposure are not altered by a high-fat diet in mice |
| Q39426025 | The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients. |
| Q91878017 | The prognostic values of neutrophil to lymphocyte ratio for outcomes in chronic obstructive pulmonary disease |
| Q37691543 | The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults |
| Q34700195 | The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD). |
| Q37352225 | The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease |
| Q34425006 | The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis |
| Q37168309 | The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year |
| Q39200222 | The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. |
| Q49087290 | The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease. |
| Q37686174 | The role of oxidative stress in COPD: current concepts and perspectives |
| Q43769126 | The serum levels of adiponectin and leptin in mustard lung patients |
| Q26778906 | The stats are in: an update on statin use in COPD |
| Q37827897 | The use of wound healing assessment methods in psychological studies: a review and recommendations |
| Q37723779 | The value of coronary artery calcium score in the early diagnosis of coronary artery disease in patients with stable chronic obstructive pulmonary disease |
| Q36750478 | Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease |
| Q53495310 | Time course of cigarette smoke-induced changes of systemic inflammation and muscle structure. |
| Q64284804 | Trabecular Bone Score Is More Sensitive to Asthma Severity and Glucocorticoid Treatment Than Bone Mineral Density in Asthmatics |
| Q61804572 | Trabecular bone score in active or former smokers with and without COPD |
| Q37419691 | Trachea epithelium as a "canary" for cigarette smoking-induced biologic phenotype of the small airway epithelium |
| Q42243161 | Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner |
| Q34065967 | Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. |
| Q51631534 | Two Lovely Black Eyes; Oh, what a surprise! |
| Q22305600 | Undernutrition in patients with COPD and its treatment |
| Q35574530 | Use of cluster analysis to describe desaturator phenotypes in COPD: correlations between pulmonary function tests and nocturnal oxygen desaturation |
| Q36570336 | Use of glucosamine and chondroitin in relation to mortality |
| Q37242596 | Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study |
| Q62731130 | Validation of Predictive Metabolic Syndrome Biomarkers of World Trade Center Lung Injury |
| Q33745696 | Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency |
| Q36225586 | What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines |
| Q90319514 | When kidneys and lungs suffer together |
| Q35658791 | Whey peptide-based enteral diet attenuated elastase-induced emphysema with increase in short chain fatty acids in mice |
| Q38966893 | Why Is Your Patient Still Short of Breath? Understanding the Complex Pathophysiology of Dyspnea in Chronic Kidney Disease |
| Q33797611 | Will expanded ART use reduce the burden of HIV-associated chronic lung disease? |
| Q82707710 | [COPD and systemic inflammation. A link for comorbidity] |
| Q85045912 | [COPD: bronchial and systemic inflammation] |
| Q82707715 | [Cardiovascular comorbidity in COPD] |
| Q54374977 | [Cardiovascular manifestations in patients with COPD]. |
| Q81103931 | [Chronic obstructive pulmonary disease and cardiovascular risk] |
| Q51158797 | [Comorbidities in COPD]. |
| Q79840217 | [Comorbidities of COPD] |
| Q81039574 | [From lung research to lung health] |
| Q79918388 | [Pathogenesis of chronic obstructive pulmonary disease] |
| Q83401068 | [Role of inflammation in the etiopathogenesis of COPD] |
| Q82707789 | [Role of physical activity in chronic obstructive pulmonary disease] |
| Q82707734 | [Skeletal muscle dysfunction in COPD] |
| Q37978685 | β-blockade: benefits beyond blood pressure reduction? |
Search more.